Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
6.38
+0.77 (13.73%)
At close: Aug 13, 2025, 4:00 PM
6.50
+0.12 (1.88%)
After-hours: Aug 13, 2025, 5:06 PM EDT
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$947,583
Market Cap
19.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PASG News
- 1 day ago - Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 4 weeks ago - Passage Bio Announces 1-for-20 Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update - GlobeNewsWire
- 3 months ago - Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Passage Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 6 months ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates - GlobeNewsWire
- 10 months ago - Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire